[HN Gopher] Early Improvements with Atogepant for the Preventive...
___________________________________________________________________
Early Improvements with Atogepant for the Preventive Treatment of
Migraine
Author : taubek
Score : 11 points
Date : 2024-12-26 16:40 UTC (6 hours ago)
(HTM) web link (www.neurology.org)
(TXT) w3m dump (www.neurology.org)
| mmastrac wrote:
| Looks like a CGRP blocker
| (https://en.wikipedia.org/wiki/Calcitonin_gene-related_peptid...)
| sold under the name Qulipta
| (https://en.wikipedia.org/wiki/Atogepant):
|
| > Since the discovery of calcitonin gene-related peptide (CGRP)
| in 1982, its integral role in migraine pathophysiology,
| specifically migraine pain, has been demonstrated through
| cumulative scientific discoveries that have led to the
| development and approval of migraine-specific therapeutics.
| Today, eight drugs, including monoclonal antibodies and small
| molecule CGRP receptor antagonists, known as gepants, have
| received approval for acute or preventive treatment of migraine.
| The primary mechanism of these drugs is to block CGRP signaling,
| thus preventing CGRP-mediated nociception and neurogenic
| inflammation. Here, we focus on atogepant, a highly potent and
| selective gepant and the first and only oral medication approved
| for the preventive treatment of both episodic and chronic
| migraine in adults. In this article, we summarize the role of
| CGRP in migraine pathophysiology and the mechanism of action of
| atogepant. In addition, we provide an overview of atogepant's
| pharmacology and the key clinical trials and outcomes that have
| demonstrated the safety and efficacy of atogepant.
|
| https://pmc.ncbi.nlm.nih.gov/articles/PMC10777605/
___________________________________________________________________
(page generated 2024-12-26 23:01 UTC)